In July 2016, it was announced that LabCorp would acquire Sequenom in a cash tranaction. In May 2014 Sequenom had sold to newly formed Agena Bioscience all the assets and related intellectual property of Sequenom Inc.s bioscience business, which developed, manufactured, and sells genetic analysis instruments and tools, software, reagents, and consumables for research applications. Sequenom, Inc., a life sciences company, had provided genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. Sequenom has developed a broad range of laboratory tests with a focus on prenatal and ophthalmological diseases and conditions. Branded under the names HerediT, MaterniT21® PLUS, RetnaGene, SensiGene® and VisibiliT, these molecular genetic laboratory-developed tests provide early patient management information for obstetricians, geneticists, maternal fetal medicine specialists and ophthalmologists. Squenom operates laboratories at its headquarters in San Diego; Grand Rapids, Michigan; and Morrisville, North Carolina.
